ReviewFrontiers in oncology2022
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance.
Dominika Kwiatkowska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Dominika Kwiatkowska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.